Zoetis return-on-equity fundamental analysis lookup allows you to check this and other indicators for Zoetis or any other equity instrument. You can also select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools
Zoetis Return On Equity Analysis
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how effecently a company utilizes investments to generate income.
For most industries Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Based on latest financial disclosure Zoetis has Return On Equity of 62%. This is 361.16% lower than that of the Healthcare sector, and 17785.71% higher than that of Drug Manufacturers - Specialty & Generic industry, The Return On Equity for all stocks is 20293.55% lower than the firm.
Did you try this?
Run Correlation Analysis Now
Reduce portfolio risk simply by holding instruments which are not perfectly correlated